Polycomb Antagonism is a regulatory mechanism in epigenetics that counteracts the gene silencing activity of Polycomb group proteins, thereby promoting transcriptional activation and maintaining active gene expression states during development and cellular differentiation.
29
Publications
4.1K
Citations
279
Authors
88
Institutions
Publications per year
2017–2026
11
Parents
Publications
29
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
Boris G. Wilson, Xi Wang, Xiaohua Shen et al. · Cancer Cell · 2010 · 641 citations · Full text
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
Jung Kim, Yongik Lee, Xiaodong Lü et al. · Cell Reports · 2018 · 310 citations · Full text
1–5 of 29
Authors
279
- CW
3
h-index
- PV
3
h-index
- ND
2
h-index
- RS
2
h-index
- FS
2
h-index
1–5 of 279
Institutions
88
Broad Institute
Cambridge, United States
4 h-index
15 publications
1.8K citations
Harvard University
Cambridge, United States
4 h-index
25 publications
8K citations
Dana-Farber Cancer Institute
Boston, United States
4 h-index
28 publications
9.7K citations
Howard Hughes Medical Institute
Chevy Chase, United States
4 h-index
20 publications
2.6K citations
Karolinska Institutet
Stockholm, Sweden
2 h-index
13 publications
1.1K citations
NYU Langone’s Laura and Isaac Perlmutter Cancer Center
New York, United States
2 h-index
12 publications
1.3K citations
Case Western Reserve University
Cleveland, United States
2 h-index
11 publications
1.9K citations
Harvard Stem Cell Institute
Cambridge, United States
2 h-index
2 publications
664 citations
1–8 of 88
Venues
- Cancer Cell
3 publications · 930 citations
3
h-index
- Development
2 publications · 226 citations
2
h-index
- Proceedings of the National Academy of Sciences
PNAS · 2 publications · 410 citations
2
h-index
- Immunity
1 publications · 185 citations
1
h-index
- Cell
1 publications · 241 citations
1
h-index
1–5